CEFTAROLINE FOSAMIL

CEFTAROLINE FOSAMIL was reported 839 times

CEFTAROLINE FOSAMIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA STAGE IV 2 0.0488
1 ANTI-PLATELET FACTOR 4 ANTIBODY POSITIVE 1 0.0435
2 LATENT SYPHILIS 1 0.0435
3 ASYMPTOMATIC BACTERIURIA 3 0.0221
4 EOSINOPHILS URINE PRESENT 1 0.0189
5 ADMINISTRATION SITE OEDEMA 1 0.0116
6 PORTAL VEIN DILATATION 1 0.0112
7 TULARAEMIA 1 0.0103
8 THROMBOANGIITIS OBLITERANS 1 0.0096
9 AUTOIMMUNE NEPHRITIS 2 0.0091
10 RENAL FAILURE NEONATAL 2 0.0090
11 INCISION SITE INFLAMMATION 1 0.0085
12 PANCREATIC HAEMORRHAGE 1 0.0076
13 PERICARDITIS INFECTIVE 1 0.0072
14 OSTEOMYELITIS ACUTE 3 0.0055
15 ADMINISTRATION SITE DISCOMFORT 1 0.0053
16 SEPTIC PULMONARY EMBOLISM 1 0.0051
17 GRANULOCYTOSIS 1 0.0051
18 PLACENTAL INSUFFICIENCY 4 0.0050
19 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
20 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
21 VESTIBULAR MIGRAINE 1 0.0041
22 FINE MOTOR DELAY 1 0.0039
23 CULTURE WOUND POSITIVE 1 0.0038
24 RENAL ISCHAEMIA 2 0.0037
25 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
26 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
27 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
28 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
29 TONGUE EXFOLIATION 1 0.0028
30 SJS-TEN OVERLAP 2 0.0028
31 PUBIS FRACTURE 2 0.0028
32 GASTROINTESTINAL TRACT ADENOMA 1 0.0027
33 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
34 PROCALCITONIN INCREASED 3 0.0026
35 TONGUE ERYTHEMA 2 0.0024
36 WOUND INFECTION BACTERIAL 1 0.0024
37 FLUID INTAKE REDUCED 12 0.0024
38 CANDIDA TEST POSITIVE 1 0.0024
39 GINGIVAL ERYTHEMA 2 0.0023
40 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
41 HYPERTRANSAMINASAEMIA 16 0.0023
42 VULVOVAGINAL RASH 1 0.0023
43 EOSINOPHILIC PNEUMONIA 7 0.0022
44 THROMBOCYTOPENIC PURPURA 3 0.0022
45 AGRANULOCYTOSIS 40 0.0021
46 INTERVERTEBRAL DISCITIS 4 0.0021
47 PLACENTAL DISORDER 2 0.0021
48 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
49 CUTANEOUS VASCULITIS 7 0.0019
50 INFECTIOUS COLITIS 1 0.0019
51 HYPOPERFUSION 2 0.0019
52 LINEAR IGA DISEASE 3 0.0018
53 PRODUCT CLOSURE ISSUE 1 0.0018
54 INTRAVASCULAR HAEMOLYSIS 1 0.0018
55 CATHETER SITE DISCHARGE 2 0.0018
56 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
57 CATHETER SITE INFLAMMATION 1 0.0018
58 VACCINATION SITE PAIN 1 0.0017
59 SPINAL EPIDURAL HAEMATOMA 1 0.0017
60 PSOAS ABSCESS 1 0.0016
61 BACILLUS INFECTION 1 0.0016
62 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
63 ATROPHY 3 0.0015
64 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
65 PSEUDOMONAS INFECTION 13 0.0015
66 EOSINOPHILIA 26 0.0015
67 PNEUMOTHORAX SPONTANEOUS 1 0.0015
68 THROAT LESION 1 0.0015
69 STASIS DERMATITIS 1 0.0015
70 PELVIC FLUID COLLECTION 1 0.0014
71 BACTERIAL DISEASE CARRIER 1 0.0014
72 SKIN STRIAE 2 0.0013
73 MICTURITION FREQUENCY DECREASED 1 0.0013
74 DEBRIDEMENT 1 0.0013
75 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33 0.0013
76 MYCOPLASMA INFECTION 1 0.0013
77 EXTRADURAL ABSCESS 1 0.0013
78 LONG QT SYNDROME 3 0.0013
79 RENAL ABSCESS 1 0.0012
80 PSEUDOMONAS TEST POSITIVE 1 0.0012
81 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
82 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 1 0.0012
83 LIP PRURITUS 1 0.0012
84 TONGUE PRURITUS 1 0.0012
85 HILAR LYMPHADENOPATHY 1 0.0011
86 ABDOMINAL SEPSIS 1 0.0011
87 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
88 SKIN TEST POSITIVE 1 0.0011
89 KLEBSIELLA BACTERAEMIA 1 0.0011
90 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
91 FIBROSIS 3 0.0010
92 ENTEROCOCCAL BACTERAEMIA 1 0.0009
93 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
94 ACINETOBACTER INFECTION 1 0.0009
95 PSEUDOMEMBRANOUS COLITIS 2 0.0009
96 PATHOGEN RESISTANCE 8 0.0009
97 EPIDIDYMITIS 1 0.0009
98 ESCHERICHIA BACTERAEMIA 2 0.0008
99 BONE MARROW TOXICITY 1 0.0008
100 ACUTE LUNG INJURY 1 0.0008
101 ORAL MUCOSA EROSION 1 0.0008
102 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
103 HAEMARTHROSIS 7 0.0008
104 ENDOCARDITIS 4 0.0008
105 HAEMOLYSIS 6 0.0008
106 WOUND SECRETION 3 0.0008
107 SKIN WRINKLING 2 0.0007
108 DRUG SPECIFIC ANTIBODY 1 0.0007
109 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
110 STAPHYLOCOCCAL INFECTION 24 0.0007
111 CYTOMEGALOVIRUS INFECTION 12 0.0007
112 RASH MACULO-PAPULAR 16 0.0007
113 VASCULAR PURPURA 1 0.0007
114 MAST CELL ACTIVATION SYNDROME 1 0.0007
115 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
116 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
117 VASCULAR INJURY 1 0.0007
118 RENAL INFARCT 1 0.0007
119 FOOT AMPUTATION 1 0.0007
120 BACTERAEMIA 8 0.0007
121 SUSPECTED OFF LABEL USE 3 0.0007
122 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
123 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
124 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
125 TRANSAMINASES INCREASED 14 0.0006
126 ENTEROCOCCAL INFECTION 3 0.0006
127 SKIN EROSION 2 0.0006
128 INFLAMMATORY MARKER INCREASED 3 0.0006
129 SEBORRHOEIC DERMATITIS 1 0.0006
130 EOSINOPHIL COUNT INCREASED 5 0.0006
131 STEVENS-JOHNSON SYNDROME 13 0.0006
132 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
133 MYCOBACTERIAL INFECTION 1 0.0006
134 INCORRECT STORAGE OF DRUG 1 0.0006
135 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
136 SPLENIC INFARCTION 1 0.0006
137 NEUTROPENIA 77 0.0006
138 HAEMOLYTIC ANAEMIA 5 0.0006
139 SOFT TISSUE INFECTION 1 0.0005
140 CYSTIC FIBROSIS 3 0.0005
141 ENCEPHALOPATHY 13 0.0005
142 PANCREATIC CYST 1 0.0005
143 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
144 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
145 OCCULT BLOOD POSITIVE 1 0.0005
146 HYPERAEMIA 1 0.0005
147 SKIN ULCER 13 0.0005
148 FUNGAL SKIN INFECTION 2 0.0005
149 EXTRAVASATION 2 0.0005
150 SPINAL STENOSIS 2 0.0005
151 INFUSION SITE EXTRAVASATION 3 0.0005
152 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
153 HEPATIC CYTOLYSIS 6 0.0005
154 AORTIC VALVE INCOMPETENCE 2 0.0005
155 LEUKOPENIA 23 0.0005
156 CLOSTRIDIUM TEST POSITIVE 1 0.0005
157 HEPATOTOXICITY 10 0.0004
158 MENINGITIS ASEPTIC 2 0.0004
159 PRODUCT LABEL ISSUE 3 0.0004
160 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
161 ISCHAEMIA 2 0.0004
162 ENCEPHALITIS 3 0.0004
163 REACTION TO EXCIPIENT 1 0.0004
164 NEUROLOGICAL DECOMPENSATION 1 0.0004
165 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
166 DISCOURAGEMENT 1 0.0004
167 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
168 URINARY TRACT OBSTRUCTION 1 0.0004
169 HAEMATOTOXICITY 4 0.0004
170 PRE-ECLAMPSIA 2 0.0004
171 OXYGEN CONSUMPTION INCREASED 1 0.0004
172 DIABETES INSIPIDUS 1 0.0004
173 GLOMERULONEPHRITIS 1 0.0004
174 ASCITES 12 0.0004
175 STAPHYLOCOCCAL SEPSIS 2 0.0004
176 HYPERPARATHYROIDISM SECONDARY 1 0.0004
177 EXPOSURE VIA INGESTION 1 0.0004
178 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
179 NOCARDIOSIS 1 0.0004
180 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
181 APNOEA 3 0.0004
182 EXFOLIATIVE RASH 1 0.0004
183 AREFLEXIA 1 0.0004
184 WHITE BLOOD CELL DISORDER 1 0.0004
185 DENTAL CARIES 4 0.0004
186 RASH MORBILLIFORM 1 0.0004
187 PANCYTOPENIA 20 0.0004
188 DIABETIC COMA 1 0.0004
189 HYPOPHAGIA 9 0.0004
190 DUODENAL ULCER HAEMORRHAGE 1 0.0003
191 SKIN ATROPHY 2 0.0003
192 STRIDOR 1 0.0003
193 ACUTE KIDNEY INJURY 52 0.0003
194 GROWTH RETARDATION 1 0.0003
195 PROTHROMBIN TIME PROLONGED 2 0.0003
196 METABOLIC ENCEPHALOPATHY 1 0.0003
197 THYROIDITIS 1 0.0003
198 THROMBOCYTOPENIA 37 0.0003
199 FOETAL GROWTH RESTRICTION 2 0.0003
200 MASTICATION DISORDER 1 0.0003
201 IRON DEFICIENCY ANAEMIA 3 0.0003
202 ARTERIOSCLEROSIS 3 0.0003
203 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
204 PNEUMONIA VIRAL 1 0.0003
205 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
206 THROMBOTIC MICROANGIOPATHY 3 0.0003
207 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
208 BACTERIAL SEPSIS 1 0.0003
209 THROMBOSIS IN DEVICE 1 0.0003
210 SKIN INJURY 1 0.0003
211 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
212 TOXIC SKIN ERUPTION 3 0.0003
213 CANDIDA INFECTION 5 0.0003
214 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
215 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
216 WOUND COMPLICATION 1 0.0003
217 BLOOD CREATININE ABNORMAL 1 0.0003
218 NECROTISING FASCIITIS 1 0.0003
219 TREATMENT FAILURE 23 0.0003
220 OEDEMA 15 0.0003
221 OSTEOMYELITIS 5 0.0003
222 ORAL DISORDER 2 0.0003
223 WOUND HAEMORRHAGE 1 0.0003
224 CARDIAC DYSFUNCTION 1 0.0003
225 NEPHROPATHY TOXIC 3 0.0003
226 HAEMODYNAMIC INSTABILITY 2 0.0003
227 CARDIOPULMONARY FAILURE 1 0.0003
228 AZOTAEMIA 1 0.0003
229 ARTHRITIS BACTERIAL 1 0.0002
230 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
231 LIP OEDEMA 1 0.0002
232 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
233 PURULENT DISCHARGE 1 0.0002
234 RENAL FAILURE 31 0.0002
235 ANURIA 2 0.0002
236 HEPATIC FAILURE 7 0.0002
237 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
238 DYSPHEMIA 1 0.0002
239 PURPURA 2 0.0002
240 DRUG ERUPTION 4 0.0002
241 RESPIRATORY RATE INCREASED 2 0.0002
242 VASCULAR DEVICE INFECTION 1 0.0002
243 ABDOMINAL HERNIA 1 0.0002
244 IMMUNE THROMBOCYTOPENIA 1 0.0002
245 PRODUCT STORAGE ERROR 19 0.0002
246 NEPHROGENIC ANAEMIA 1 0.0002
247 SKIN ABRASION 1 0.0002
248 SUBCUTANEOUS ABSCESS 1 0.0002
249 KIDNEY TRANSPLANT REJECTION 1 0.0002
250 SEPTIC SHOCK 9 0.0002
251 FLUID OVERLOAD 3 0.0002
252 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
253 BREATH SOUNDS ABNORMAL 1 0.0002
254 HYPERVOLAEMIA 1 0.0002
255 DIABETIC NEUROPATHY 1 0.0002
256 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
257 DERMATITIS EXFOLIATIVE 1 0.0002
258 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
259 KLEBSIELLA INFECTION 1 0.0002
260 DRUG LEVEL DECREASED 2 0.0002
261 PHLEBITIS 1 0.0002
262 DEVICE RELATED INFECTION 3 0.0002
263 PRODUCT COLOUR ISSUE 1 0.0002
264 DRUG RESISTANCE 5 0.0002
265 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
266 CEREBRAL ISCHAEMIA 1 0.0002
267 MALABSORPTION 1 0.0002
268 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
269 RASH ERYTHEMATOUS 9 0.0002
270 GINGIVITIS 1 0.0002
271 NORMAL NEWBORN 1 0.0002
272 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
273 SKIN INFECTION 2 0.0002
274 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
275 FACE OEDEMA 3 0.0002
276 HYPOKALAEMIA 8 0.0002
277 STRESS CARDIOMYOPATHY 1 0.0002
278 NEUROTOXICITY 3 0.0002
279 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
280 MYOCLONUS 2 0.0002
281 HEARING IMPAIRED 1 0.0002
282 CYTOPENIA 2 0.0002
283 OFF LABEL USE 141 0.0002
284 DERMATITIS ALLERGIC 2 0.0002
285 ACUTE RESPIRATORY FAILURE 3 0.0002
286 HAEMATOMA 4 0.0002
287 HEPATITIS ACUTE 1 0.0002
288 BLOOD CREATININE INCREASED 10 0.0002
289 WALKING AID USER 1 0.0002
290 APPETITE DISORDER 1 0.0002
291 ADVERSE REACTION 2 0.0002
292 BRONCHIECTASIS 1 0.0001
293 PNEUMONITIS 4 0.0001
294 NEPHROTIC SYNDROME 1 0.0001
295 SKIN LESION 4 0.0001
296 HYPERKALAEMIA 5 0.0001
297 MOUTH ULCERATION 3 0.0001
298 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
299 FAECES DISCOLOURED 3 0.0001
300 TONGUE DISORDER 1 0.0001
301 DERMATITIS BULLOUS 1 0.0001
302 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
303 RESPIRATORY FAILURE 10 0.0001
304 UTERINE LEIOMYOMA 1 0.0001
305 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
306 ARTHROPOD BITE 1 0.0001
307 RASH PAPULAR 3 0.0001
308 TROPONIN INCREASED 1 0.0001
309 RENAL FAILURE CHRONIC 1 0.0001
310 HYPOALBUMINAEMIA 1 0.0001
311 PULMONARY HAEMORRHAGE 1 0.0001
312 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
313 ABSCESS 2 0.0001
314 TRANSPLANT REJECTION 1 0.0001
315 DECUBITUS ULCER 1 0.0001
316 SPINAL COMPRESSION FRACTURE 1 0.0001
317 HEMIPLEGIA 1 0.0001
318 SKIN PLAQUE 1 0.0001
319 BLOOD MAGNESIUM DECREASED 1 0.0001
320 RASH GENERALISED 3 0.0001
321 PYELONEPHRITIS 1 0.0001
322 DEAFNESS 3 0.0001
323 THROAT TIGHTNESS 3 0.0001
324 OROPHARYNGEAL DISCOMFORT 1 0.0001
325 LEUKOCYTOSIS 2 0.0001
326 ANAEMIA 21 0.0001
327 C-REACTIVE PROTEIN INCREASED 4 0.0001
328 PNEUMONIA BACTERIAL 1 0.0001
329 MENTAL STATUS CHANGES 3 0.0001
330 ERYTHEMA MULTIFORME 1 0.0001
331 NEPHROPATHY 1 0.0001
332 PHOTOPHOBIA 2 0.0001
333 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
334 RASH 46 0.0001
335 PRODUCT PACKAGING ISSUE 1 0.0001
336 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
337 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
338 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
339 CHOLESTASIS 2 0.0001
340 CHILLS 12 0.0001
341 PHARYNGEAL SWELLING 1 0.0001
342 RENAL TUBULAR NECROSIS 1 0.0001
343 HEPATOMEGALY 1 0.0001
344 THERAPY CHANGE 1 0.0001
345 HOSPICE CARE 1 0.0001
346 LIGAMENT SPRAIN 1 0.0001
347 RESPIRATORY DISORDER 3 0.0001
348 PREMATURE BABY 3 0.0001
349 PERITONITIS BACTERIAL 1 0.0001
350 PYREXIA 34 0.0001
351 TOOTH ABSCESS 1 0.0001
352 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
353 HYPERBILIRUBINAEMIA 1 0.0001
354 VENTRICULAR EXTRASYSTOLES 1 0.0001
355 RHABDOMYOLYSIS 4 0.0001
356 PETECHIAE 1 0.0001
357 PRODUCT ODOUR ABNORMAL 1 0.0001
358 RENAL IMPAIRMENT 8 0.0001
359 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
360 JOINT DISLOCATION 1 0.0001
361 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
362 RENAL FAILURE ACUTE 4 0.0001
363 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
364 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
365 RASH PRURITIC 5 0.0001
366 OSTEONECROSIS 3 0.0001
367 WOUND INFECTION 1 0.0001
368 BLOOD GLUCOSE FLUCTUATION 1 0.0001
369 ANAPHYLACTIC REACTION 5 0.0001
370 FEBRILE NEUTROPENIA 6 0.0001
371 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
372 MEDICATION ERROR 5 0.0001
373 SKIN DISORDER 3 0.0001
374 HYPERTENSIVE CRISIS 1 0.0001
375 MALNUTRITION 1 0.0001
376 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
377 MITRAL VALVE INCOMPETENCE 1 0.0001
378 DRUG INTERACTION 14 0.0001
379 ELECTROLYTE IMBALANCE 1 0.0001
380 VASCULITIS 1 0.0001
381 COVID-19 15 0.0001
382 DISEASE PROGRESSION 10 0.0001
383 BLOOD IRON DECREASED 1 0.0001
384 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
385 NOCTURIA 1 0.0001
386 NO THERAPEUTIC RESPONSE 1 0.0001
387 HYPERCALCAEMIA 1 0.0001
388 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
389 AGEUSIA 2 0.0001
390 HYPOTENSION 16 0.0001
391 CELLULITIS 4 0.0001
392 INTRAOCULAR PRESSURE INCREASED 1 0.0001
393 MYDRIASIS 1 0.0001
394 THERAPY CESSATION 4 0.0001
395 ORAL CANDIDIASIS 1 0.0001
396 TOOTH INFECTION 1 0.0001
397 PRURITUS 29 0.0001
398 NEUTROPHIL COUNT DECREASED 3 0.0001
399 TACHYPNOEA 1 0.0001
400 ACUTE HEPATIC FAILURE 1 0.0001
401 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
402 ORAL DISCOMFORT 1 0.0001
403 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
404 HEPATOCELLULAR INJURY 1 0.0001
405 SINUS TACHYCARDIA 1 0.0001
406 BRONCHOSPASM 1 0.0001
407 MYELODYSPLASTIC SYNDROME 1 0.0001
408 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
409 HAEMOGLOBIN DECREASED 7 0.0001
410 RENAL INJURY 2 0.0001
411 HAEMORRHAGE INTRACRANIAL 1 0.0001
412 HYPOAESTHESIA ORAL 1 0.0001
413 BLOOD COUNT ABNORMAL 1 0.0001
414 PHARYNGEAL OEDEMA 1 0.0001
415 ANKLE FRACTURE 1 0.0001
416 LUNG INFECTION 1 0.0001
417 EXPOSURE DURING PREGNANCY 4 0.0001
418 EJECTION FRACTION DECREASED 1 0.0001
419 BRAIN FOG 1 0.0001
420 DRUG-INDUCED LIVER INJURY 2 0.0001
421 PNEUMOTHORAX 1 0.0001
422 SEPSIS 7 0.0001
423 INTERSTITIAL LUNG DISEASE 3 0.0001
424 LUNG DISORDER 3 0.0001
425 DRUG LEVEL INCREASED 1 0.0001
426 BLOOD PRESSURE DECREASED 4 0.0001
427 COAGULOPATHY 1 0.0001
428 BLOOD UREA INCREASED 1 0.0001
429 HAEMATURIA 2 0.0001
430 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
431 MUSCULOSKELETAL DISCOMFORT 1 0.0001
432 MULTI-ORGAN FAILURE 1 0.0001
433 OEDEMA PERIPHERAL 7 0.0001
434 RASH MACULAR 2 0.0001
435 CEREBRAL HAEMORRHAGE 2 0.0001
436 DEATH 48 0.0001
437 TOOTHACHE 1 0.0001
438 END STAGE RENAL DISEASE 1 0.0001
439 BACTERIAL INFECTION 1 0.0001
440 BLISTER 3 0.0001
441 OXYGEN SATURATION DECREASED 3 0.0001
442 DYSARTHRIA 2 0.0001
443 HYPOCALCAEMIA 1 0.0001
444 GASTRIC ULCER 1 0.0001
445 PROTEINURIA 1 0.0001
446 CONVULSION 3 0.0001
447 PRESCRIBED OVERDOSE 1 0.0001
448 DYSPHONIA 3 0.0001
449 PREGNANCY 1 0.0000
450 CARDIAC FAILURE 4 0.0000
451 FULL BLOOD COUNT DECREASED 1 0.0000
452 CONFUSIONAL STATE 8 0.0000
453 TASTE DISORDER 1 0.0000
454 BONE MARROW FAILURE 1 0.0000
455 BODY TEMPERATURE INCREASED 1 0.0000
456 DRUG INEFFECTIVE 64 0.0000
457 PRODUCT USE ISSUE 9 0.0000
458 DERMATITIS 1 0.0000
459 LIVER FUNCTION TEST INCREASED 1 0.0000
460 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
461 HEART RATE IRREGULAR 1 0.0000
462 HEPATIC ENZYME INCREASED 3 0.0000
463 SKIN DISCOLOURATION 2 0.0000
464 SHOCK 1 0.0000
465 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
466 OCULAR HYPERAEMIA 2 0.0000
467 PRODUCTIVE COUGH 2 0.0000
468 DIABETIC KETOACIDOSIS 1 0.0000
469 LOCALISED INFECTION 1 0.0000
470 PRESYNCOPE 1 0.0000
471 LIVER INJURY 1 0.0000
472 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
473 CARDIOVASCULAR DISORDER 1 0.0000
474 HEPATITIS 1 0.0000
475 UNRESPONSIVE TO STIMULI 1 0.0000
476 DIPLOPIA 1 0.0000
477 RESPIRATORY TRACT INFECTION 1 0.0000
478 MUCOSAL INFLAMMATION 1 0.0000
479 MUSCULOSKELETAL PAIN 2 0.0000
480 GASTRITIS 1 0.0000
481 PANCREATITIS 2 0.0000
482 EAR INFECTION 1 0.0000
483 PLATELET COUNT DECREASED 4 0.0000
484 THROMBOSIS 3 0.0000
485 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
486 LIMB INJURY 1 0.0000
487 PALLOR 1 0.0000
488 TREATMENT NONCOMPLIANCE 2 0.0000
489 RESPIRATORY DISTRESS 1 0.0000
490 CONDITION AGGRAVATED 11 0.0000
491 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
492 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
493 HYPERSOMNIA 1 0.0000
494 SEIZURE 4 0.0000
495 LIVER FUNCTION TEST ABNORMAL 1 0.0000
496 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
497 ACUTE MYOCARDIAL INFARCTION 1 0.0000
498 TACHYCARDIA 3 0.0000
499 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
500 HYPERSENSITIVITY 6 0.0000
501 SWOLLEN TONGUE 1 0.0000
502 VOMITING 15 0.0000
503 CYSTITIS 1 0.0000
504 METABOLIC ACIDOSIS 1 0.0000
505 DRUG INTOLERANCE 3 0.0000
506 HYPERHIDROSIS 4 0.0000
507 DEEP VEIN THROMBOSIS 2 0.0000
508 SWELLING FACE 2 0.0000
509 CHOLELITHIASIS 1 0.0000
510 EYE DISORDER 1 0.0000
511 TREMOR 5 0.0000
512 VISUAL ACUITY REDUCED 1 0.0000
513 VIRAL INFECTION 1 0.0000
514 FUNGAL INFECTION 1 0.0000
515 URTICARIA 5 0.0000
516 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
517 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
518 ERYTHEMA 6 0.0000
519 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
520 DELIRIUM 1 0.0000
521 NEOPLASM PROGRESSION 1 0.0000
522 HEART RATE DECREASED 1 0.0000
523 HYPOXIA 1 0.0000
524 MYELOSUPPRESSION 1 0.0000
525 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
526 AGITATION 2 0.0000
527 CHEST PAIN 5 0.0000
528 EYE SWELLING 1 0.0000
529 BACK PAIN 6 0.0000
530 ABDOMINAL PAIN 6 0.0000
531 BLINDNESS 1 0.0000
532 LUNG NEOPLASM MALIGNANT 1 0.0000
533 CARDIAC ARREST 2 0.0000
534 FALL 8 0.0000
535 NAUSEA 19 0.0000
536 ABDOMINAL DISCOMFORT 4 0.0000
537 WITHDRAWAL SYNDROME 1 0.0000
538 RECTAL HAEMORRHAGE 1 0.0000
539 DEVICE DISLOCATION 1 0.0000
540 DYSPNOEA 13 0.0000
541 DEHYDRATION 3 0.0000
542 PULMONARY OEDEMA 1 0.0000
543 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
544 GASTROINTESTINAL DISORDER 2 0.0000
545 THROAT IRRITATION 1 0.0000
546 DIARRHOEA 14 0.0000
547 RENAL DISORDER 1 0.0000
548 CARDIAC DISORDER 2 0.0000
549 DYSPHAGIA 2 0.0000
550 INFECTION 3 0.0000
551 HYPOGLYCAEMIA 1 0.0000
552 FLUID RETENTION 1 0.0000
553 CHEST DISCOMFORT 2 0.0000
554 NERVOUSNESS 1 0.0000
555 HAEMORRHAGE 2 0.0000
556 SPEECH DISORDER 1 0.0000
557 ASTHENIA 7 0.0000
558 PNEUMONIA 6 0.0000
559 NECK PAIN 1 0.0000
560 COUGH 5 0.0000
561 HYPONATRAEMIA 1 0.0000
562 MYALGIA 3 0.0000
563 URINARY TRACT INFECTION 3 0.0000
564 WHEEZING 1 0.0000
565 PLEURAL EFFUSION 1 0.0000
566 DISCOMFORT 1 0.0000
567 PRODUCT DOSE OMISSION 1 0.0000
568 INFUSION RELATED REACTION 1 0.0000
569 NEOPLASM MALIGNANT 1 0.0000
570 SOMNOLENCE 3 0.0000
571 PRODUCT QUALITY ISSUE 2 0.0000
572 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
573 BURNING SENSATION 1 0.0000
574 THERAPY INTERRUPTED 1 0.0000
575 MOBILITY DECREASED 1 0.0000
576 PAIN IN EXTREMITY 4 0.0000
577 DYSGEUSIA 1 0.0000
578 EPISTAXIS 1 0.0000
579 CHRONIC KIDNEY DISEASE 1 0.0000
580 BLOOD PRESSURE INCREASED 2 0.0000
581 HOSPITALISATION 2 0.0000
582 PERIPHERAL SWELLING 2 0.0000
583 DECREASED APPETITE 3 0.0000
584 FATIGUE 10 0.0000
585 CARDIAC FAILURE CONGESTIVE 1 0.0000
586 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
587 DIZZINESS 6 0.0000
588 SKIN EXFOLIATION 1 0.0000
589 CEREBROVASCULAR ACCIDENT 2 0.0000
590 BALANCE DISORDER 1 0.0000
591 INTENTIONAL PRODUCT MISUSE 1 0.0000
592 MALAISE 5 0.0000
593 PAIN 7 0.0000
594 ADVERSE DRUG REACTION 1 0.0000
595 NO ADVERSE EVENT 2 0.0000
596 OROPHARYNGEAL PAIN 1 0.0000
597 SWELLING 1 0.0000
598 PULMONARY EMBOLISM 1 0.0000
599 NEUROPATHY PERIPHERAL 1 0.0000
600 GAIT DISTURBANCE 2 0.0000
601 DYSPEPSIA 1 0.0000
602 HEART RATE INCREASED 1 0.0000
603 SYNCOPE 1 0.0000
604 FLUSHING 1 0.0000
605 ABDOMINAL PAIN UPPER 2 0.0000
606 ILLNESS 1 0.0000
607 ABDOMINAL DISTENSION 1 0.0000
608 HEADACHE 6 0.0000
609 WEIGHT INCREASED 2 0.0000
610 ASTHMA 1 0.0000
611 MUSCULAR WEAKNESS 1 0.0000
612 DEPRESSION 2 0.0000
613 PALPITATIONS 1 0.0000
614 INSOMNIA 2 0.0000
615 VISION BLURRED 1 0.0000
616 PRODUCT DOSE OMISSION ISSUE 2 0.0000
617 HYPOAESTHESIA 1 0.0000
618 PARAESTHESIA 1 0.0000
619 TOXICITY TO VARIOUS AGENTS 1 0.0000
620 MYOCARDIAL INFARCTION 1 0.0000
621 MUSCLE SPASMS 1 0.0000
622 NASOPHARYNGITIS 1 0.0000
623 BLOOD GLUCOSE INCREASED 1 0.0000
624 ALOPECIA 1 0.0000
625 ARTHRALGIA 2 0.0000
626 CONSTIPATION 1 0.0000
627 INCORRECT DOSE ADMINISTERED 1 0.0000
628 FEELING ABNORMAL 1 0.0000
629 ANXIETY 1 0.0000
630 INJECTION SITE PAIN 1 0.0000